Wei Lei
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Genetics top 5%
- Mesenchymal stem cell research
Papers in
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 5
Wei Lei
92 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 428
- Genetics 168
- Molecular Biology 910
- Pathology and Forensic Medicine 236
- Immunology 241
Countries citing papers authored by Wei Lei
This map shows the geographic impact of Wei Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lei more than expected).
Fields of papers citing papers by Wei Lei
This network shows the impact of papers produced by Wei Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lei. The network helps show where Wei Lei may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 25 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 4 | |
| 9 | Advances in the role of STAT3 in macrophage polarization Hit paper breakdown → | 2023 | 151 |
| 10 | 2023 | 8 | |
| 11 | 2023 | 4 | |
| 12 | 2021 | 2 | |
| 13 | TMPO-AS1, a Novel E2F1-Regulated lncRNA, Contributes to the Proliferation of Lung Adenocarcinoma Cells via Modulating miR-326/SOX12 Axis | 2020 | 1 |
| 14 | 2020 | 19 | |
| 15 | 2020 | 17 | |
| 16 | 2019 | 8 | |
| 17 | 2019 | 77 | |
| 18 | 2017 | 14 | |
| 19 | Which is the appropriate surgical procedure for Stage I endometrial carcinoma? | 2015 | 2 |
| 20 | Azithromycin inhibits double-stranded RNA-induced thymic stromal lymphopoietin release from human airway epithelial cells. | 2013 | 6 |
About Wei Lei
Wei Lei is a scholar working on Microbiology, Cancer Research, Immunology, Critical Care and Intensive Care Medicine and Aging, having authored 99 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (14 papers), Tissue Engineering and Regenerative Medicine (10 papers), Congenital heart defects research (8 papers), Asthma and respiratory diseases (6 papers), Immune Cell Function and Interaction (5 papers), MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (428 citations), Genetics (168 citations), Molecular Biology (910 citations), Pathology and Forensic Medicine (236 citations) and Immunology (241 citations). Wei Lei has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shijun Hu, Zhen‐Ao Zhao, Junjie Yang, Jianan Huang, Yehan Zhu, Yueqiu Chen, Zhenya Shen, Zhenya Shen, Ruilin Yang and Sheng-Ping Fu. Their work appears in journals such as Stem Cell Research & Therapy, Frontiers in Cell and Developmental Biology, Cardiovascular Research, BMC Pulmonary Medicine and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.